StonvexLoading…
StonvexStonvexStonvexCore line items from BX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $14.45B | $13.23B | $8.02B | $8.52B |
Operating Income | $7.17B | $6.46B | $2.96B | $3.46B |
Net Income | $3.02B | $2.78B | $1.39B | $1.75B |
EPS (Diluted) | $3.87 | $3.62 | $1.84 | $2.36 |
Total Assets | $47.71B | $43.47B | $40.29B | $42.52B |
Total Liabilities | $25.83B | $23.97B | $22.21B | $22.84B |
Cash & Equivalents | $2.63B | $1.97B | $2.96B | $4.25B |
Free Cash Flow OCF − CapEx | $4.55B | $3.42B | $3.83B | $6.10B |
Shares Outstanding | 748.69M | 731.93M | 719.36M | 710.28M |